2 completed, 1 active not recruiting, 1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow Ulla Feldt-Rasmussen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cardiac Symptoms in Patients With Treated Graves' Disease Graves Disease, Cardiac Arrhythmias | Active not recruiting | Ulla Feldt-Rasmussen | 75 | 2021-09-20 | 2025-04-03 | |
| Modified-release Compared to Conventional Hydrocortisone on Diurnal Fatigue in Secondary Hypoadrenalism Hydrocortisone, Plenadren - Adrenal Insufficiency | Phase 4 | Unknown | Ulla Feldt-Rasmussen | 30 | 2016-10-01 | 2017-02-23 |
| Fabry: Renal Function During Long-term ERT by 51Cr-EDTA Clearance Enzyme replacement therapy - Fabry Disease | Completed | Ulla Feldt-Rasmussen | 52 | 2015-04-01 | 2018-10-16 | |
| Cardiac Involvement in Adult Patients With Fabry Disease; Relation to Enzyme Replacement Therapy Fabry Disease | Completed | Ulla Feldt-Rasmussen | 66 | 2014-11-01 | 2018-10-16 |
Fabry Disease (2) · Adrenal Insufficiency (1) · Arrhythmias, Cardiac (1) · Cardiomyopathy, Hypertrophic (1) · Fatigue (1) · Graves Disease (1) · Hypertrophy, Left Ventricular (1) · Kidney Diseases (1)
Enzyme Replacement Therapy (1) · Hydrocortisone (1) · agalsidase alfa (1) · agalsidase beta (1)
Denmark (2)
Ulla V Feldt-Rasmussen, MD, DMSc (1)
2014 (1)